Duhaylungsod, Elsie T.

HRN: 13-74-32  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/08/2023
09/14/2023
IV
600mg
Q6H
None Healing Wound
Waiting Final Action 
09/08/2023
CEFTRIAXONE 1G (VIAL)
09/08/2023
09/14/2023
IV
2gm
Q24H
CAP MR
Waiting Final Action 
09/08/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/08/2023
09/14/2023
IV
1.5gm
Q6H
Non Healing Wound
Waiting Final Action 
09/11/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/11/2023
09/17/2023
IVT
4.5g
Q6
CAP MR; Osteomyelitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: